BH
BHCCF.US Benchmark Holdings plc
- Market cap
- USD 225M
- P/E
- -
- P/B
- 0.66x
- ROE
- 50.5%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Mar 2025.
Is BHCCF.US undervalued?
Graham numberThe Graham number of Benchmark Holdings plc cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Benchmark Holdings plc fundamental analysis
No fundamental analysis for Benchmark Holdings plc yet.
Benchmark Holdings plc stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Benchmark Holdings plc
Benchmark Holdings plc, together with its subsidiaries, engages in the provision of technical services, products, and specialist knowledge that supports the development of food and farming industries. It operates through Genetics, Advanced Nutrition, and Health segments. The Genetics segment offers sea bass and bream, salmon, and shrimp breeding technologies and production facilities to the harnesses industry to provide various genetic merit ova. The Advanced Nutrition segme…
Full company profileBenchmark Holdings plc financial statements
2025 annualized: Fiscal year 2025 is not finished. Income statement and cash flow are annualized from 2 quarters up to Mar 31, 2025, the balance sheet is the latest quarter. Figures change when the annual report is published.
Benchmark Holdings plc annual financial statements (GBP; K = thousand, M = million, B = billion, T = trillion)
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 44.2M | 109M | 140M | 151M | 127M | 106M | 125M | 158M | 169M | 90.4M | 81.3M |
| Gross Profit | 16.1M | 50.8M | 62.4M | 74.0M | 66.0M | 55.0M | 65.6M | 83.9M | 86.8M | 43.9M | 39.1M |
| Operating Income | -11.6M | -20.5M | -7.66M | -9.06M | -61.3M | -10.9M | -5.38M | -6.23M | -5.32M | -35.5M | -16.7M |
| EBITDA | -6.96M | -4.58M | 11.6M | 18.8M | 30.9M | 14.3M | 23.5M | 34.4M | 24.1M | 11.0M | 3.62M |
| Net Income | -12.0M | -18.3M | -7.44M | -5.01M | -83.9M | -32.9M | -12.9M | -32.1M | -23.1M | -39.5M | 153M |
| EPS | -0.06 | -0.04 | -0.01 | -0.01 | -0.15 | -0.05 | -0.02 | -0.05 | -0.03 | -0.05 | 0.21 |
| Balance Sheet | |||||||||||
| Total Assets | 134M | 511M | 507M | 553M | 503M | 489M | 482M | 527M | 471M | 385M | 424M |
| Total Liabilities | 42.0M | 143M | 148M | 171M | 193M | 194M | 202M | 203M | 189M | 161M | 121M |
| Shareholders' Equity | 91.2M | 366M | 354M | 376M | 304M | 289M | 272M | 313M | 276M | 218M | 303M |
| Cash & Short-term Investments | 13.6M | 38.1M | 18.8M | 24.1M | 16.1M | 71.6M | 39.5M | 36.4M | 36.5M | 23.1M | 208M |
| Total Debt | 156K | 37.7M | 42.7M | 79.8M | 103M | 109M | 120M | 110M | 102M | 72.1M | 81.6M |
| Cash Flow | |||||||||||
| Operating Cash Flow | -8.96M | -10.5M | 13.4M | -3.74M | -9.21M | -4.06M | 5.79M | 10.8M | 20.0M | 2.00M | 5.71M |
| Capital Expenditure | 14.2M | 20.2M | 35.2M | 32.7M | 15.8M | 11.4M | 22.7M | 12.7M | 6.78M | 3.93M | 4.71M |
| Free Cash Flow | -23.2M | -30.7M | -21.8M | -36.4M | -25.0M | -15.5M | -16.9M | -1.91M | 13.2M | -1.92M | 996K |
| Ratios | |||||||||||
| ROE | -13.2% | -5.0% | -2.1% | -1.3% | -27.6% | -11.4% | -4.7% | -10.2% | -8.4% | -18.1% | 50.5% |
| ROA | -8.9% | -3.6% | -1.5% | -0.9% | -16.7% | -6.7% | -2.7% | -6.1% | -4.9% | -10.3% | 36.1% |
| Net Profit Margin | -27.1% | -16.8% | -5.3% | -3.3% | -65.9% | -31.2% | -10.3% | -20.3% | -13.7% | -43.7% | 188.3% |
| Debt to Equity | 0.00x | 0.10x | 0.12x | 0.21x | 0.34x | 0.38x | 0.44x | 0.35x | 0.37x | 0.33x | 0.27x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Benchmark Holdings plc dividends
Benchmark Holdings plc has not paid dividends in the last 9 fiscal years.
Who owns Benchmark Holdings plc
- Insiders 9.14%
- Institutions 90.86%
- Public & others 0.00%
- Shares outstanding 615M
- Free float 59.5M
Benchmark Holdings plc company profile
- Company name
- Benchmark Holdings plc
- Ticker
- BHCCF.US
- Exchange
- USA Stocks
- Sector
- Consumer Defensive
- Industry
- Pharmaceuticals
- Employees
- 800
- Fiscal year end
- September
- Address
- 4 Park Square, Sheffield, United Kingdom, BN99 3HH
- Phone
- 44 11 4240 9939
- Website
- benchmarkplc.com
About Benchmark Holdings plc
Benchmark Holdings plc, together with its subsidiaries, engages in the provision of technical services, products, and specialist knowledge that supports the development of food and farming industries. It operates through Genetics, Advanced Nutrition, and Health segments. The Genetics segment offers sea bass and bream, salmon, and shrimp breeding technologies and production facilities to the harnesses industry to provide various genetic merit ova. The Advanced Nutrition segment manufactures and provides nutrition and health products to the aquaculture industry. The Health segment provides health products, including Ectosan Vet and CleanTreat medicinal sea lice solutions to the aquaculture market. The company operates in the United Kingdom, Norway, Vietnam, Iceland, the Faroe Islands, China, Ecuador, India, Canada, Greece, Chile, Turkey, rest of the Europe, and internationally. Benchmark Holdings plc was incorporated in 2000 and is headquartered in Sheffield, the United Kingdom.
Benchmark Holdings plc management
10- Mr. Patrick WatyChief Executive Officer
- Ms. Ruth LaytonCo-Founder & Head of Benchmark Sustainability Science · born 1954
- Mr. Pierre HugoChief Financial Officer
- Mr. Neil RobertsonHead of Operations
- Ms. Ivonne Maria Gloria CantuSecretary, Director of Investor Relations & Corpo Development and Head of Sustainability · born 1968
- Ms. Corina HolmesGroup Head of People
- Mr. Roland James BonneyGroup Lead of Key Account Management · born 1964
- Mr. David BabingtonManaging Director of Improve International
- Mr. Bob LongManaging Director of Benchmark Vaccines Ltd
- Dr. Jonas Jónasson Ph.D.Global Production Director for Salmon - Benchmark Genetics